Our own Dr. LA DiMeglio presenting on #t1d #prevention at the #pearl meeting in Portland! Lots of great discussions - including Type 1 Diabetes TrialNet screening and info on our open new onset and prevention studies. DiabDocs-K12 Michael Haller, M.D. Dr. Carmella EvansMolina (photo credit to Janet Y Lee, MD, MPH, MAS (she/her))!

We are a site here in Indianapolis! Let us know if you want more information!

Yes! Consider #campjohnwarvel! June 9-15. Center for Diabetes and Metabolic Diseases Camp John Warvel Camp Crosley YMCA

⚠️ This is your last chance to apply for the #ISPAD Science School for Physicians 2024. It will take place in Pittsburgh, Pennsylvania, USA, September 22-27! Apply before Feb 16, 2024! ➡️ Please click here to read all the information: loom.ly/EEQ9q7Q #SSP #Research

Great to see our team recognized for this work in Type 1 Diabetes TrialNet and is move to the clinical arena! Emily K. Sims Dr. Carmella EvansMolina Jamie Felton @natedejong115 Dr. LA DiMeglio JDRF Indiana & Kentucky

🎉Great news! Two IU School of Medicine faculty investigators recently received esteemed awards from @JDRF recognizing their valuable contributions to #T1DResearch. Big congratulations to Dr. Linda DiMeglio (Dr. LA DiMeglio) & Dr. Viral Shah! More on their awards: medicine.iu.edu/blogs/faculty-…

Congrats to these members of our Type 1 Diabetes Connection team! #jdrf Dr. LA DiMeglio #t1d

And Kids! Proud that our team was part of this work!

Our Dr. LA DiMeglio giving a talk at #ENDO2024 on advances in early stage #t1d. Presenting new monitoring guidance coming out soon in Diabetes Care, a research journal of the ADA 🌟 and Diabetologia. Highlighting Type 1 Diabetes TrialNet studies and DiabDocs-K12. #breakthrought1d @JDRF Heba Center for Diabetes and Metabolic Diseases

Same mission, New name. Breakthrough T1D (formerly JDRF) is the world leader in T1D research, advocacy, and community support. Our new brand reflects our bold vision for a world without T1D. We are accelerating breakthroughs and building a movement for change. #BreakthroughT1D

Very proud of these two scientists as well! Dr. Carmella EvansMolina and Dr. LA DiMeglio! Riley Children's Indiana University Research IU Department of Pediatrics IU School of Medicine Women Inspiring & Elevating Leadership in Diabetes

We spy our own Maria Spall here with this great group at a recent Breakthrough T1D clinical trials event!! linkedin.com/posts/albanese…

Are you a parent of a child with #t1d. Please consider completing this survey!

#ISPAD Clinical Practice Consensus #Guidelines 2024. "Chapter 17: Diabetes Technologies: Insulin Delivery " is ready! We look forward to receiving your comments until September 23, 2024 by clicking here: loom.ly/zh8hLrU !

Our local Type 1 Diabetes Connection team is here at IU Indianapolis for the 2024 Breakthrough T1D walk! Stop by to find out more about #screening for #t1d. Dr. Carmella EvansMolina Dr. LA DiMeglio Riley Children's IU Department of Pediatrics Herman B Wells Center for Pediatric Research Center for Diabetes and Metabolic Diseases Type 1 Diabetes TrialNet

Next week, on Dec 3 at 7 PM CET, we’re bringing together Dr. Kirstine Bell and Prof. Eduardo Calliari to discuss the future of Type 1 #DiabetesScreening. This is your opportunity to learn about real-world solutions for early T1D detection 🔗 Register now: loom.ly/CTmLEtQ

T1D symptoms are caused by high blood sugar levels (glucose) and may be mistaken for severe flu or another illness. T1D develops over time. But once it reaches stage 3, symptoms may come on quickly and be life-threatening. Get screened at trialnet.org/participate

A new consensus statement on screening and staging for Type 1 Diabetes in children and adolescents has been released by the International Society for Pediatric and Adolescent Diabetes (ISPAD) this week. This international effort was led by Michael Haller, M.D. , Chief of Pediatric